Sensus Healthcare Inc

Healthcare US SRTS

4.25USD
-0.1(2.30%)

Last update at 2026-03-10T20:00:00Z

Day Range

4.224.44
LowHigh

52 Week Range

1.796.55
LowHigh

Fundamentals

  • Previous Close 4.35
  • Market Cap96.23M
  • Volume67826
  • P/E Ratio20.24
  • Dividend Yield-%
  • EBITDA5.72M
  • Revenue TTM31.65M
  • Revenue Per Share TTM1.95
  • Gross Profit TTM 29.63M
  • Diluted EPS TTM0.29

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 27.99M 4.12M -6.83553M -1.70000M -2.02276M
Minority interest - - - - -
Net income 24.24M 4.12M -4.71531M -1.15429M -2.02276M
Selling general administrative 5.01M 4.59M 3.99M 4.00M 4.12M
Selling and marketing expenses 6.33M 4.84M 5.34M 9.10M 8.53M
Gross profit 29.63M 16.99M 5.25M 17.56M 16.91M
Reconciled depreciation 0.32M 0.61M 0.72M 0.55M 0.66M
Ebit 14.83M 3.51M -8.23387M -1.96829M -2.52433M
Ebitda 15.21M 4.12M -9.57967M -1.70000M -1.86608M
Depreciation and amortization 0.38M 0.61M -1.34579M 0.27M 0.66M
Non operating income net other 13.16M 0.00100M 1.41M 0.27M 0.14M
Operating income 14.83M 4.12M -8.23387M -1.96829M -2.00535M
Other operating expenses 29.70M 22.92M 17.81M 29.23M 28.43M
Interest expense 0.00200M 0.00100M 0.01M 0.00000M 0.16M
Tax provision 3.75M - - - -
Interest income 0.38M 0.00200M 0.07M 0.27M 0.14M
Net interest income 0.38M -0.00100M 0.05M 0.27M -0.01741M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 3.75M -0.61300M -2.12021M -0.54572M 0.14M
Total revenue 44.53M 27.04M 9.58M 27.26M 26.43M
Total operating expenses 14.80M 12.87M 13.48M 19.53M 18.92M
Cost of revenue 14.90M 10.05M 4.33M 9.71M 9.52M
Total other income expense net 13.16M -0.00100M 1.40M 0.27M -0.01741M
Discontinued operations - - - - -
Net income from continuing ops 24.24M 4.12M -6.83553M -1.70000M -2.02276M
Net income applicable to common shares 24.24M 4.12M -6.83553M -1.70000M -2.02276M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 53.73M 56.73M 32.24M 28.01M 36.92M
Intangible assets - 0.05M 0.15M 0.34M 0.34M
Earning assets - - - - -
Other current assets 0.89M 7.39M 2.84M 2.06M 1.51M
Total liab 4.88M 8.67M 6.22M 6.51M 8.92M
Total stockholder equity 48.84M 48.07M 26.02M 21.50M 28.00M
Deferred long term liab - 0.14M 0.26M 0.58M 1.34M
Other current liab 0.57M 1.29M 0.51M 0.19M 0.19M
Common stock 0.17M 0.17M 0.17M 0.17M 0.17M
Capital stock 0.17M 0.17M 0.17M 0.17M 0.17M
Retained earnings 6.79M 6.30M -17.94200M -22.06106M -15.22553M
Other liab - 0.14M 0.26M 0.58M 1.34M
Good will - - - - -
Other assets 0.00000M - 0.07M 0.07M 0.10M
Cash 23.15M 25.52M 14.52M 14.91M 8.10M
Cash and equivalents - - - - -
Total current liabilities 4.21M 7.70M 5.96M 4.86M 6.47M
Current deferred revenue 0.66M 0.69M 1.17M 1.49M 1.19M
Net debt -22.36500M -24.50000M -14.29400M -13.52467M -6.67523M
Short term debt 0.19M 0.19M 0.23M 0.30M 0.31M
Short long term debt - - 0.05M - -
Short long term debt total 0.78M 1.02M 0.23M 1.38M 1.43M
Other stockholder equity 41.89M 41.60M 43.79M 43.39M 43.06M
Property plant equipment - 0.24M 0.77M 1.36M 2.48M
Total current assets 49.53M 53.71M 31.25M 25.17M 34.00M
Long term investments - - - - -
Net tangible assets - 48.02M 25.87M 21.16M 27.66M
Short term investments - - - 0.00000M 7.39M
Net receivables 10.64M 17.30M 12.13M 3.78M 14.01M
Long term debt - - - 0.27M -
Inventory 14.85M 3.50M 1.76M 4.43M 3.00M
Accounts payable 2.79M 5.52M 4.06M 2.87M 4.78M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.00000M - - - -1.23027M
Additional paid in capital - - - - -
Common stock total equity - 0.17M 0.17M 0.17M 0.17M
Preferred stock total equity - - - - -
Retained earnings total equity - 6.30M -17.94200M -22.06106M -15.22554M
Treasury stock - -3.43300M -0.32500M -0.30990M -0.25257M
Accumulated amortization - - - - -
Non currrent assets other 0.80M 0.02M 0.07M 0.07M 0.10M
Deferred long term asset charges - - - - -
Non current assets total 4.20M 3.03M 0.99M 2.84M 2.92M
Capital lease obligations 0.78M 1.02M 0.17M 1.12M 1.43M
Long term debt total - - - 0.27M -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 14.84M 0.13M 7.39M -4.49722M -1.78756M
Change to liabilities 0.00000M 0.33M -2.76294M 0.37M 1.86M
Total cashflows from investing activities 14.84M 0.13M 7.03M -4.89781M -2.64239M
Net borrowings - -0.21600M 0.27M 0.27M -2.21497M
Total cash from financing activities -2.42800M -0.23100M 0.21M 2.62M 13.60M
Change to operating activities - -0.76600M -0.49552M 0.25M -1.31633M
Net income 24.24M 4.12M -6.83553M -1.70000M -2.02276M
Change in cash 11.00M -0.38800M 6.81M -4.38397M 2.40M
Begin period cash flow 14.52M 14.91M 8.10M 12.48M 10.09M
End period cash flow 25.52M 14.52M 14.91M 8.10M 12.48M
Total cash from operating activities -1.41200M -0.28600M -0.43418M -2.10664M -8.56373M
Issuance of capital stock - - - 0.00000M 17.25M
Depreciation 0.32M 0.61M 0.72M 0.55M 0.66M
Other cashflows from investing activities 15.00M 0.26M - -4.49722M -1.78756M
Dividends paid - - - - -
Change to inventory -3.19100M 2.73M -1.42999M -1.69852M -0.66142M
Change to account receivables -5.31400M -8.43200M 10.25M -1.21533M -8.17440M
Sale purchase of stock -2.99900M - 0.00056M 2.74M 15.94M
Other cashflows from financing activities 0.62M -0.01500M 0.21M 2.62M -3.64509M
Change to netincome -25.65600M -4.40500M 6.40M -0.40664M -6.54097M
Capital expenditures 0.16M 0.13M 0.36M 0.40M 0.85M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes 11.00M -0.38800M 6.81M -4.38397M 2.40M
Change in working capital -12.73000M -6.13800M 5.56M -2.30220M -8.29038M
Stock based compensation 0.19M 0.41M 0.39M 0.62M 0.98M
Other non cash items -11.71500M -0.03800M -0.58801M 0.73M 0.11M
Free cash flow -1.57100M -0.41400M -0.79273M -2.50724M -9.41856M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
SRTS
Sensus Healthcare Inc
-0.1 2.30% 4.25 20.24 42.19 2.27 1.13 1.35 416.25
ABT
Abbott Laboratories
-2.1 1.86% 110.55 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation
-7.27 1.99% 358.65 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC
-1.45 1.59% 89.89 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp
-1.94 2.70% 69.96 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

Profile

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Sensus Healthcare Inc

851 Broken Sound Parkway NW, Boca Raton, FL, United States, 33487

Key Executives

Name Title Year Born
Mr. Joseph C. Sardano Co-Founder, Chairman & CEO 1953
Mr. Michael J. Sardano Pres & Gen. Counsel 1989
Mr. Javier Rampolla Chief Financial Officer 1973
Mr. Nicolas Soro Chief Operating Officer 1985
Mr. Benson Suen VP of International Sales NA
Dr. Mark S. Nestor Medical Director & Member of Medical Advisory Board NA
Dr. Clay Jefferies Cockerell Clinical Director & Member of Medical Advisory Board 1957
Mr. Michael J. Sardano President, General Counsel, Corporate Secretary & Director 1989
Ms. Magdalena Martinez Chief Operating Officer 1990
Mr. Emiliano Sosa Chief Technology Officer 1978

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.